Home/Filings/4/0001127602-25-005225
4//SEC Filing

Alexander Kristen 4

Accession 0001127602-25-005225

CIK 0001062822other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:22 PM ET

Size

7.8 KB

Accession

0001127602-25-005225

Insider Transaction Report

Form 4
Period: 2025-02-13
Alexander Kristen
VP, Finance and Accounting
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-02-13+185,540185,540 total
    Exercise: $0.69Exp: 2035-02-13Common Stock (185,540 underlying)
  • Award

    Restricted Stock Units

    2025-02-13+185,540185,540 total
    Common Stock (185,540 underlying)
Footnotes (3)
  • [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1
  • filerCIK 0001878867

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:22 PM ET
Size
7.8 KB